Overview

Detection of Functioning Pituitary Microadenoma: PET/MRI Versus PET/CT

Status:
Unknown status
Trial end date:
2018-11-01
Target enrollment:
0
Participant gender:
All
Summary
This is a prospective case-control study to compare the usefulness of 18F-FDG PET/MRI with that of 18F-FDG PET/CT in detection of functioning pituitary microadenomas.A single dose of 370 Mega-Becquerel (MBq) 18F-FDG will be injected intravenously.Visual and semiquantitative method will be used to assess the PET/MRI and PET/CT images.
Phase:
Phase 1
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Peking Union Medical College Hospital
Treatments:
Fluorodeoxyglucose F18
Criteria
Inclusion Criteria:

- Patients who were pathologically diagnosed with pituitary adenoma after surgery were
recruited, and were able to provide basic information and sign the written informed
consent form.

Exclusion Criteria:

- The exclusion criteria included claustrophobia, kidney or liver failure, and inability
to fulfill the study.